Our proprietary, full-stack Physilog platform delivers powerful 3D motion analytics to capture, measure, and analyse a new generation of digital biomarkers and digital endpoints.

A healthy adult will walk 200,000,000 steps during their lifetime. Motion is considered our 6th vital sign, and motion biomarkers are reliable indicators of health and wellbeing. But more than one billion individuals suffer from mobility impairments, arising from a neurological or musculoskeletal condition.

Physilog combines wearable motion sensors, powerful biomechanical fusion algorithms and a suite of clinical tests to deliver detailed patient-centric digital motion assessments at the point of need.

We are addressing the challenge of integrating motion analysis solutions across the continuum-of-care for patients with mobility disorders, thus enabling a new generation of gait biomarkers and digital endpoints to assess human motion at scale.

The Census companion software suite, which is accessible on mobile app or through the Cloud, uses Physilog data to correlate measured mobility with therapy exposure. This insight informs program design and health-economic analysis.

Since its launch in 2013, the Physilog platform has earned the trust of a global life science and academic research community in more than 30 countries.

Physilog has been used to assess more than 10,000 subjects and has been referenced in 500+ publications.

Since its launch in 2013, the Physilog platform has earned the trust of a global life science and academic research community in more than 30 countries.

Physilog has been used to assess more than 10,000 subjects and has been referenced in 500+ publications.